Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Public ClinicalTrials.gov record NCT01211873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Study identification
- NCT ID
- NCT01211873
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Guerbet
- Industry
- Enrollment
- 416 participants
Conditions and interventions
Interventions
- Dotarem (gadoterate meglumine) Drug
- Magnevist (gadopentetate dimeglumine) Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2010
- Primary completion
- Oct 31, 2011
- Completion
- Oct 31, 2011
- Last update posted
- Apr 17, 2019
2010 – 2011
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham, UABMC | Birmingham | Alabama | 35233 | — |
| University Medical Center | Tucson | Arizona | 47404 | — |
| University medical center | Tucson | Arizona | 85724 | — |
| Desert Medical Imaging | Indian Wells | California | 47404 | — |
| Sunrise Clinical Research, Inc. | Hollywood | Florida | 33021 | — |
| Children's Memorial Hospital | Chicago | Illinois | 60614 | — |
| Precise Clinical Research Solutions | Topeka | Kansas | 66604 | — |
| University of Louisville Hospital | Louisville | Kentucky | 40202 | — |
| Neurocare Center for Research | Brookline | Massachusetts | 02446 | — |
| University of Michigan | Ann Arbor | Michigan | 48109 | — |
| QUEST Research Institute | Farmington Hills | Michigan | 48334 | — |
| Gruss Magnetic resonance Research Clinic | New York | New York | 10461 | — |
| WestImage - Division of Research | Cincinnati | Ohio | 45248 | — |
| Ohio State University | Columbus | Ohio | 47404 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| University of Texas - Health Science Center | San Antonio | Texas | 47404 | — |
| UTHSCSA | San Antonio | Texas | 47404 | — |
| Clinical Trials of Texas, Inc. | San Antonio | Texas | 78229 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01211873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2019 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01211873 live on ClinicalTrials.gov.